share_log

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt

Telomir Pharmaceuticals | 3:首次持股声明-董事 Whalen Matthew Pratt
美股SEC公告 ·  08/15 11:22
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息